★ Sign in to follow
PC

Paul Chow

Shareholder
CA·SEDI
Genix Pharmaceuticals Corporation
Total declarations
29
Company
1
▲ Purchases (27 ops.)
€67k
▼ Sales (0 ops.)
—

Latest filing published 28 Dec 2023 for Genix Pharmaceuticals Corporation, €508.

Filing timeline

BuySale
Paul Chow

Insider track record

Disclosed buys
27
Disclosed sells
0
Signal history

Paul Chow: trading record in brief

This profile gathers the share dealings of Paul Chow in Genix Pharmaceuticals Corporation. The record holds 29 filings, for trades running from 30 December 2020 to 27 December 2023.

No open-market sale appears; the market trades are 27 purchases worth €67k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 4 purchases and no sales.

Half of the purchases are above €1,932 and half below. Across 24 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 28 December 2023, the filings show an open-market purchase worth €508 in Genix Pharmaceuticals Corporation. The median gap between a trade and its publication by SEDI is 1 day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paul Chow

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    740 CAD13SEDI
    37,000 shares@ CA$0.020.2% of flowCommon SharesTSXSEDI:4232066
    Canonical exit: 26 Mar 2024 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    5,250 CAD11SEDI
    150,000 shares@ CA$0.0351.6% of flowCommon SharesTSXSEDI:4228738
    Canonical exit: 17 Mar 2024 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    3,355 CAD11SEDI
    61,000 shares@ CA$0.0550.8% of flowCommon SharesTSXSEDI:4149917
    Canonical exit: 26 Sept 2023 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    1,000 CAD11SEDI
    20,000 shares@ CA$0.050.2% of flowCommon SharesTSXSEDI:4149916
    Canonical exit: 26 Sept 2023 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    720 CAD0SEDI
    9,000 shares@ CA$0.08Common SharesTSXSEDI:4007682
    Canonical exit: 26 Dec 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    330 CAD0SEDI
    3,000 shares@ CA$0.11Common SharesTSXSEDI:3995034
    Canonical exit: 27 Nov 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    110 CAD0SEDI
    1,000 shares@ CA$0.11Common SharesTSXSEDI:3993606
    Canonical exit: 22 Nov 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    12,500 CAD17SEDI
    100,000 shares@ CA$0.1253.1% of flowCommon SharesTSXSEDI:3870940
    Canonical exit: 17 Apr 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    3,570 CAD17SEDI
    34,000 shares@ CA$0.1051.1% of flowCommon SharesTSXSEDI:3856005
    Canonical exit: 24 Mar 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,990 CAD13SEDI
    23,000 shares@ CA$0.130.9% of flowCommon SharesTSXSEDI:3853888
    Canonical exit: 3 Mar 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,800 CAD13SEDI
    20,000 shares@ CA$0.140.9% of flowCommon SharesTSXSEDI:3853890
    Canonical exit: 3 Mar 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,400 CAD17SEDI
    16,000 shares@ CA$0.150.7% of flowCommon SharesTSXSEDI:3825497
    Canonical exit: 31 Jan 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    85 CAD17SEDI
    500 shares@ CA$0.170.0% of flowCommon SharesTSXSEDI:3819098
    Canonical exit: 13 Jan 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    4,165 CAD17SEDI
    24,500 shares@ CA$0.171.2% of flowCommon SharesTSXSEDI:3817737
    Canonical exit: 11 Jan 2022 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    3,150 CAD13SEDI
    17,500 shares@ CA$0.180.9% of flowCommon SharesTSXSEDI:3807584
    Canonical exit: 23 Dec 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,188 CAD13SEDI
    12,500 shares@ CA$0.1750.6% of flowCommon SharesTSXSEDI:3807582
    Canonical exit: 23 Dec 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    3,800 CAD17SEDI
    20,000 shares@ CA$0.190.9% of flowCommon SharesTSXSEDI:3796688
    Canonical exit: 29 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,000 CAD17SEDI
    10,000 shares@ CA$0.200.5% of flowCommon SharesTSXSEDI:3794805
    Canonical exit: 24 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    3,780 CAD17SEDI
    21,000 shares@ CA$0.180.9% of flowCommon SharesTSXSEDI:3791035
    Canonical exit: 15 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    7,920 CAD17SEDI
    44,000 shares@ CA$0.182.0% of flowCommon SharesTSXSEDI:3791282
    Canonical exit: 16 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    4,400 CAD17SEDI
    22,000 shares@ CA$0.201.1% of flowCommon SharesTSXSEDI:3787852
    Canonical exit: 8 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    2,535 CAD17SEDI
    13,000 shares@ CA$0.1950.6% of flowCommon SharesTSXSEDI:3787854
    Canonical exit: 8 Nov 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    600 CAD17SEDI
    3,000 shares@ CA$0.200.1% of flowCommon SharesTSXSEDI:3782450
    Canonical exit: 27 Oct 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    190 CAD17SEDI
    1,000 shares@ CA$0.190.0% of flowCommon SharesTSXSEDI:3782455
    Canonical exit: 27 Oct 2021 (T+90)
  • ▲
    Paul Chow
    3 - 10% Security Holder of Issuer, 4 - Director of IssuerExecutivesGenix Pharmaceuticals Corporation
    1,400 CAD17SEDI
    7,000 shares@ CA$0.200.3% of flowCommon SharesTSXSEDI:3782109
    Canonical exit: 26 Oct 2021 (T+90)

25 of 29 declarations

Related entities

No related entities found.